HOME >> MEDICINE >> NEWS
NIAID study results support diluting smallpox vaccine stockpile to stretch supply

HHS Secretary Tommy G. Thompson today announced that results from a key clinical trial indicate that the existing U.S. supply of smallpox vaccine-15.4 million doses-could successfully be diluted up to five times and retain its potency, effectively expanding the number of individuals it could protect from the contagious disease.

The public health implications of this study are enormously important, said Secretary Thompson. We now know that in the unlikely event of an intentional release of smallpox, our stockpile of smallpox vaccine can be expanded fivefold as we had planned. The success of this study puts us one step closer to our goal of having enough vaccine for every American if needed to respond to a potential outbreak.

Expanding the U.S. smallpox vaccine supply has been a high-priority of the HHS bioterrorism preparedness plan. In addition to expanding the existing supply of vaccine through dilution, HHS has contracted with Acambis Inc. to produce another 209 million doses of smallpox vaccine by the end of 2002. The combination of these efforts would bring the total number of doses in the smallpox vaccine stockpile to at least 286 million, and the Acambis contract gives the federal government the option to purchase even more vaccine quickly.

These encouraging results suggest that we can do more with less and thereby extend our capacity to contain a potential smallpox outbreak, said Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), which funded the research. Although the likelihood of a deliberate release of smallpox is very small, it is prudent to be prepared.

The trial compared the full-strength vaccine with fivefold, as well as tenfold, dilutions in 680 young adults with no history of smallpox vaccination. More than 97 percent of all participants in the trial responded with a vaccine take, a blister-like sore at the injection site that serves as an indirect measure o
'"/>

Contact: Laurie K. Doepel
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
28-Mar-2002


Page: 1 2 3 4

Related medicine news :

1. NIAID initiates trial of experimental avian flu vaccine
2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
3. NIAID begins enrolling volunteers for novel HIV vaccine study
4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
5. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
6. NIAID launches influenza genome sequencing project
7. NIAID launches program to improve medical tools against emerging infectious diseases
8. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
9. NIAID rotavirus vaccine licensed for commercialization
10. Second NIAID SARS vaccine candidate helps mice fend off SARS
11. NIAID vaccine protects against SARS virus infection in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... 21, 2020 , ... Representatives with Florida-based Baby Blendy ... opening discount 0n its anti-colic portable baby bottle blender. , " Order now ... Baby Blendy LLC, a member of the Juvenile Products Manufacturers Association. "This is ...
(Date:2/21/2020)... ... February 21, 2020 , ... Cosmetic surgery continues ... Society of Plastic Surgeons (ASPS). According to the ASPS, there were 17.7-million cosmetic ... over the previous year. The American Society of Plastic Surgeons reported that some ...
(Date:2/20/2020)... ... February 20, 2020 , ... R3 Medical Training announced its next joint injection ... how to perform injections for all large and small joints along with ultrasound needle ... videos. The best opportunity is to perform injections in a supervised setting. R3 Medical ...
(Date:2/20/2020)... CLARA, Calif. (PRWEB) , ... February 20, 2020 ... ... for insurance agents, has a new release with next generation API integration ... , Launched by VisitorsCoverage Inc. in 2017, TMQuotes was the first ...
(Date:2/19/2020)... ... February 19, 2020 , ... The American ... for its new Lifestyle Medicine Residency Curriculum (LMRC). The curriculum is the first ... residency programs. Driven by resident involvement, the curriculum has included residents in ...
Breaking Medicine News(10 mins):
(Date:2/19/2020)... ... February 19, 2020 , ... The Team Type 1 Foundation, a nonprofit ... everyone affected by diabetes, announced a partnership with VeloCity, a fundraising ride benefiting Grady ... VeloCity event takes place on May 2nd and begins on the Mercedes-Benz Stadium field ...
(Date:2/19/2020)... ... February 19, 2020 , ... The swine flu (H1N1) ... foot-and-mouth disease (FMD) is a potential new outbreak. Although the U.S. has eradicated ... more than two-thirds of countries in the world, posing a risk from trading partners. ...
(Date:2/15/2020)... Fla. (PRWEB) , ... February 14, 2020 , ... ... has established an "oral-systemic” link between the organisms that cause inflammatory gum disease ... from Tampa-based ProBiora Health?? , offers new tools in the fight against ...
Breaking Medicine Technology:
Cached News: